Compare iShares MSCI United Kingdom (FTSE) (EWU) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI United Kingdom (FTSE) vs Tenet Healthcare Corporation — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $46.22 (market cap $3.66B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 5.7× iShares MSCI United Kingdom (FTSE)'s market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, iShares MSCI United Kingdom (FTSE) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI United Kingdom (FTSE) for 46 Days and Tenet Healthcare Corporation for 15 Days on average.
| EWU | THC | |
|---|---|---|
Market Cap | $3.66B | $20.92B |
Volume | 573,447 | 455,764 |
Sector | Broad Market / Factor | Health |
52-Week High | $49.39 | $280.77 |
52-Week Low | $41.34 | $161.37 |
Typical Hold Time | 46 Days | 15 Days |
Enterprise Value | — | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWU, the iShares MSCI United Kingdom ETF, trades at $45.93, down 0.95% amid broader UK market pressures. Technical indicators show a bearish trend with moving averages signaling sell pressure, though RSI levels suggest potential oversold conditions. The fund faces headwinds from rising UK gilt yields and inflation concerns, while recent government support for housebuilders provides some sector-specific optimism. Financial ratios are not applicable as this is an ETF tracking UK equities.
The outlook remains cautious given macroeconomic pressures on UK markets, though oversold technical conditions may present near-term opportunities. Key risks include persistent inflation, rising interest rates, and political uncertainty surrounding the upcoming budget. Investors should monitor UK economic data and central bank policy decisions for directional cues.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI United Kingdom (FTSE)
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
